US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Nose Better Gel

Reason CGMP DEVIATIONS

Ecometics, Inc. D-0450-2023
Class II · Moderate risk Terminated

Soltice Quick-RUB

Reason CGMP DEVIATIONS

Ecometics, Inc. D-0449-2023
Class II · Moderate risk Terminated

Vencedor medicated balm

Reason CGMP DEVIATIONS

Ecometics, Inc. D-0447-2023
Class II · Moderate risk Terminated

Alcolado Relampago

Reason CGMP DEVIATIONS

Ecometics, Inc. D-0446-2023
Class III · Low risk Terminated

Fentanyl 1

Reason Subpotent Drug

SCA Pharmaceuticals NDC 70004-0200-16 D-0363-2023
Class II · Moderate risk Terminated

Clear Eyes

Reason Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.

Teva Pharmaceuticals USA Inc NDC 67172-504-01 D-0469-2023
Class II · Moderate risk Terminated

Carbidopa and Levodopa Tablets

Reason Packaging defect: observed packaging defect, blister packaging inadequately sealed.

The Harvard Drug Group NDC 0904-7257-61 D-0432-2023
Class II · Moderate risk Terminated

Sterile Water for Injection

Reason CGMP Deviations: Potential product carryover.

Nephron Sc Inc NDC 0487-6105-01 D-0364-2023
Class II · Moderate risk Terminated

Metformin hydrochloride Extended-Release Tablets

Reason CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Teva Pharmaceuticals USA Inc NDC 00591-2720-60 D-0441-2023
Class II · Moderate risk Terminated

Phenylephrine HCl Injection

Reason Lack of Assurance of Sterility

Nephron Sterile Compounding Center LLC NDC 69374-301-10 D-0361-2023
Class II · Moderate risk Terminated

Phenylephrine HCl Injection

Reason Lack of Assurance of Sterility

Nephron Sterile Compounding Center LLC NDC 69374-305-10 D-0360-2023
Class II · Moderate risk Terminated

Phenylephrine HCl Injection

Reason Lack of Assurance of Sterility

Nephron Sterile Compounding Center LLC NDC 69374-302-10 D-0359-2023
Class II · Moderate risk Terminated

Phenylephrine HCl 20 mg

Reason CGMP DEVIATIONS

Denver Solutions, LLC DBA Leiters Health NDC 71449-148-94 D-0445-2023
Class II · Moderate risk Terminated

Phenylephrine HCl 40 mg

Reason CGMP DEVIATIONS

Denver Solutions, LLC DBA Leiters Health NDC 71449-150-82 D-0444-2023
Class II · Moderate risk Terminated

Phenylephrine HCl 1mg per 10mL

Reason CGMP DEVIATIONS

Denver Solutions, LLC DBA Leiters Health NDC 71449-001-15 D-0443-2023
Class II · Moderate risk Terminated

Phenylephrine HCl 0.5 mg per 5 mL

Reason CGMP DEVIATIONS

Denver Solutions, LLC DBA Leiters Health NDC 71449-001-11 D-0442-2023
Class III · Low risk Terminated

Dibucaine 1% Hemorrhoidal Ointment

Reason Labeling: Incorrect or Missing Lot and/or Exp Date

Akron Pharma, Inc. NDC 71399-2829-1 D-0454-2023
Class III · Low risk Terminated

Gabapentin Tablets

Reason Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.

Sciegen Pharmaceuticals Inc D-0354-2023
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.

Azurity Pharmaceuticals, Inc. NDC 52536-625-10 D-0489-2023